I oppose limitations imposed by this change. Leveraged and inverse funds should be available freely as publicly traded instruments. They form an important part of my investment and existing disclosures are sufficient for me to understand risks associated with these instruments. The imposed restrictions will significantly impact liquidity associated with the trades.
These securities should be left as publicly traded like they are now.
Vivek Mishra Comment On Regulatory Notice 22-08
I oppose limitations imposed by this change. Leveraged and inverse funds should be available freely as publicly traded instruments. They form an important part of my investment and existing disclosures are sufficient for me to understand risks associated with these instruments. The imposed restrictions will significantly impact liquidity associated with the trades.
These securities should be left as publicly traded like they are now.